Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simron Singh

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.
Endocrine-Related Cancer|February 26, 2026
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo modelNilakshi Kulathunga, Rusha Chakraborty, Yan Li, et al.
Pancreas|July 18, 2020
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine TumorsThorvardur R Halfdanarson, Jonathan R Strosberg, Laura Tang, et al.
Lancet (London, England)|December 26, 2015
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 studyJames C Yao, Nicola Fazio, Simron Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus GuidelinesSimron Singh, Emily K Bergsland, Cynthia M Card, et al.
Pancreas|June 14, 2017
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine TumorsJonathan R Strosberg, Thorvardur R Halfdanarson, Andrew M Bellizzi, et al.
CMAJ Open|May 9, 2023
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort studyRui Fu, Rinku Sutradhar, Qing Li, et al.
Journal of Neuroendocrinology|May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task forceAnna Koumarianou, Pier Luigi Filosso, Lisa Bodei, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?Rui Fu, Rinku Sutradhar, Anna Dare, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.
Endocrine-Related Cancer|February 26, 2026
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo modelNilakshi Kulathunga, Rusha Chakraborty, Yan Li, et al.
Pancreas|July 18, 2020
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine TumorsThorvardur R Halfdanarson, Jonathan R Strosberg, Laura Tang, et al.
Lancet (London, England)|December 26, 2015
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 studyJames C Yao, Nicola Fazio, Simron Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus GuidelinesSimron Singh, Emily K Bergsland, Cynthia M Card, et al.
Pancreas|June 14, 2017
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine TumorsJonathan R Strosberg, Thorvardur R Halfdanarson, Andrew M Bellizzi, et al.
CMAJ Open|May 9, 2023
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort studyRui Fu, Rinku Sutradhar, Qing Li, et al.
Journal of Neuroendocrinology|May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task forceAnna Koumarianou, Pier Luigi Filosso, Lisa Bodei, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?Rui Fu, Rinku Sutradhar, Anna Dare, et al.
Pageof 15